IIFL Finance Schedules Overseas Investor Meetings June 1–5, 2026
IIFL Finance Limited has informed exchanges about scheduling investor meetings outside India from June 1 to June 5, 2026.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
12,471 articles published
IIFL Finance Limited has informed exchanges about scheduling investor meetings outside India from June 1 to June 5, 2026.
Read articleAarti Pharmalabs Limited has filed its analyst call transcript with NSE following a recent institutional investor meet. Know more about this disclosure.
Read articleCompany Update D & A Financial Services (P) Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Grand Foundry Ltd ("Target Company"). D & A Financial Services (P) Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Grand Foundry Ltd ("Target Company").
Read articleCompany Update IIFL Finance Limited informs the exchanges that the Company has scheduled meetings with institutional investors and analysts, outside India, commencing from June 01, 2026 till June 05, 2026. Enclosed herewith website link for investor presentation. IIFL Finance Limited informs the exchanges that the Company has scheduled meetings with institutional investors and analysts, outside India, commencing from June 01, 2026 till June 05, 2026. Enclosed herewith website link for investor
Read articleAarti Pharmalabs has notified NSE about a transcript from its recent institutional investor meet, giving market participants access to key discussion points from the interaction.
Read articleAarti Pharmalabs has disclosed its latest investor meet transcript on the NSE, giving market participants access to the company's discussion with analysts and institutional investors.
Read articleAarti Pharmalabs has filed a transcript of its recent analyst and institutional investor meeting with the NSE, offering stakeholders access to the discussion details.
Read articleZydus Lifesciences Limited has informed the NSE about initiating a share buyback program. Detailed parameters regarding pricing, size, and timeline are expected in the official filing.
Read articleBoard Meeting Grovy India Ltd's board meeting on 9/6/2026 to consider preferential issue of equity shares and recommend 1% final dividend of Rs. 0.10 per share for FY ended March 31, 2026,Neutral Grovy India Ltd's board meeting on 9/6/2026 to consider preferential issue of equity shares and recommend 1% final dividend of Rs. 0.10 per share for FY ended March 31, 2026,Neutral Grovy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 ,i
Read articleThe Q4 FY26 earnings call transcript for Aarti Pharmalabs is now available via BSE filing. Investors can access the full discussion covering the company's quarterly performance and strategic outlook.
Read articleZydus Lifesciences Limited (NSE: ZYDUSLIFE) has notified the exchanges about a share buyback program. The announcement signals the pharma major's intent to return capital to shareholders.
Read articleZydus Lifesciences Limited has notified the exchange about a share buyback, marking another step in the pharmaceutical company's capital optimization efforts.
Read articleOmkar Pharmachem (OMKARPH) has released its audited financial results for the quarter and full year ending March 31, 2026, through official newspaper publications as per regulatory guidelines.
Read articleNSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.